Results 181 to 190 of about 137,114 (301)

An international perspective on allocation rules for combined heart-lung transplantation. [PDF]

JHLT Open
Holm AM, Bello I, Sandiumenge A, Snell G, Gottlieb J.   +4 more
europepmc   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Pulmonary indications for heart-lung transplantation: A modified Delphi survey among the French transplantation community. [PDF]

JHLT Open
Chatron E, Renaud-Picard B, Epailly E, Demant X, Jougon J, Boulate D, Horeau-Langlard D, Mercier O, Fadel E, Olland A, Le Pavec J.   +10 more
europepmc   +1 more source

Heart-lung transplantation

The Journal of Thoracic and Cardiovascular Surgery, 1985
openaire   +2 more sources

Quadruplex Bioactive FAND for Treating Acute Liver Failure Induced by Acetaminophen or Hepatectomy

Exploration, EarlyView.
This work developed a bioactive quadruplex FANDHP@FuEVs with intrinsic inflammation‐targeting properties of M2‐EVs and MSC‐EVs, harnessing the synergistic biological activities by leveraging four natural active components—M2‐EVs, MSC‐EVs, HGF, and PPC—to deliver pleiotropic therapies, including antioxidant, anti‐inflammatory, pro‐regenerative, and M1 ...
Meng Sun, Fang Fang, Juan Liu, Yueyun Fan, Sa Wang, Chuang Zhang, Weiyu Li, Zhengyang Quan, Dongxu Zhao, Min Hu, Jinfeng Zhang   +10 more
wiley   +1 more source

Specific risk factors for heart-lung transplantation. [PDF]

JHLT Open
Issard J, Le Pavec J, Dauriat G, Valdeolmillos E, Hascoet S, Andarelli JN, Diop S, Genty T, Savale L, Mercier O, Fadel E.   +10 more
europepmc   +1 more source

A New Vista of Opportunity in Diabetes Management: Natural Product‐Based β‐cell Preservation

Food Chemistry International, EarlyView.
Preserving functional β‐cells via natural products offers promising strategy for diabetes treatment. ABSTRACT A defining characteristic of diabetes is β‐cell failure, in which β‐cells cannot modulate insulin secretion to compensate for escalating insulin resistance, pushing forward disease development.
Yi‐San Lee, Tien‐Fen Kuo, Chun‐Yen Yang, Greta Yang, Wen‐Chin Yang   +4 more
wiley   +1 more source

Heart-lung transplantation-global activity between 2003 and 2023, indications and outcomes. [PDF]

JHLT Open
Gottlieb J, Sybrecht C, Holm AM.
europepmc   +1 more source

Sternal Complications After Clamshell Surgery for (Heart-)Lung Transplantation-A Systematic Literature Review. [PDF]

Eur J Cardiothorac Surg
Klei DS, Sabaoğlu R, Mokhles MM, de Heer LM, van Wessem KJP.   +4 more
europepmc   +1 more source

En Bloc Heart-Lung Transplantation: Past and Present. A Systematic Review. [PDF]

Clin Transplant
El-Andari R, Fialka NM, Alam A, Khonde I, Weatherald J, Halloran K, Nagendran J.   +6 more
europepmc   +1 more source